• No results found

Graves' disease

Rising Serum Thyroxine Levels and Chorea in Graves’ Disease

Rising Serum Thyroxine Levels and Chorea in Graves’ Disease

... 8.7 – 13.6]; thyrotropin , 0.003 mU/L). At this time, she had lost 5 kg in 1 month, her heart rate was 120 beats per minute, and her blood pressure was 130/80 mm Hg. She reported persistence of chorei- form episodes, ...

6

Thyroid “Vise” in an Infant With Neonatal Graves’ Disease

Thyroid “Vise” in an Infant With Neonatal Graves’ Disease

... maternal Gravesdisease (GD), fetal and neonatal goiters are most commonly caused by maternal treatment with antithyroid medication, and the goiter resolves within days of initiation of thyroxine replace- ...

6

Genetic Variation of At-Hook Transcription Factor (Akna) Rs3748178 is Associated with the Relapse of Graves’ Disease

Genetic Variation of At-Hook Transcription Factor (Akna) Rs3748178 is Associated with the Relapse of Graves’ Disease

... In Graves' disease, B cells produce autoantibodies to TSH receptors that are known as Thyrotropin Receptor Antibodies (TRAb) which have two isoforms, Thyroid Stimulating Antibodies (TSAb) and ...

6

Graves’ Disease and Down Syndrome: Case Report

Graves’ Disease and Down Syndrome: Case Report

... Surgery (total thyroidectomy) is indicated in very bulky goiters (>150 g), in the existence of compressive symptoms in allergic patients or non-adherent to drug therapy, in patients who refuse treatment with ...

8

Encephalopathy associated with autoimmune thyroid disease in patients with Graves' disease: clinical manifestations, follow-up, and outcomes

Encephalopathy associated with autoimmune thyroid disease in patients with Graves' disease: clinical manifestations, follow-up, and outcomes

... have been searched by the Internet scientific research engine PubMed. "Hashimoto's encephalopathy", "enceph- alopathy associated to/with autoimmune thyroid dis- ease", "encephalopathy", ...

8

Graves’ Disease and Treatment Effects on Warfarin Anticoagulation

Graves’ Disease and Treatment Effects on Warfarin Anticoagulation

... needed to take both medications. The patient was informed that methimazole would treat her Gravesdisease and that the status of this disease would influence her response to warfarin therapy. The ...

7

Management of Neonates Born to Mothers With Graves’ Disease

Management of Neonates Born to Mothers With Graves’ Disease

... Over the course of their careers, many family doctors, pediatricians, and neonatologists will manage the offspring of a mother with Gravesdisease (GD). Such newborns are at risk for developing neonatal ...

13

Graves’ Disease in Senegal: Clinical and Evolutionary Aspects

Graves’ Disease in Senegal: Clinical and Evolutionary Aspects

... Gravesdisease is a common disease in Senegal as evidenced by the number of cases compiled over five ...a disease affecting young women and does not show any clinical feature ex- cept the ...

6

RADIOIODINE I-131 FOR THE THERAPY OF GRAVES DISEASE

RADIOIODINE I-131 FOR THE THERAPY OF GRAVES DISEASE

... Gravesdisease is a common cause of ...for Gravesdisease include antithyroid medication, surgery or radioactive iodine (I-31) or ...

9

Significant cardiac disease complicating Graves’ disease in previously healthy young adults

Significant cardiac disease complicating Graves’ disease in previously healthy young adults

... heart disease are risk factors for AF and its ...that Gravesdisease causes significant cardiac morbidity and mortality even in young individuals who have no previously known cardiac disease ...

6

A case report of graves’ disease in Liberia and surgical indication

A case report of graves’ disease in Liberia and surgical indication

... of Graves’ ...for Graves' disease: antithyroid drugs (thionamides), radioiodine, or ...manage Graves’ ...Grave’s disease (thyrotoxicosis) in patients managed with carbimazole and ...

5

RADIOIODINE TREATMENT OF GRAVES’ DISEASE –  DOSE/RESPONSE ANALYSIS

RADIOIODINE TREATMENT OF GRAVES’ DISEASE – DOSE/RESPONSE ANALYSIS

... Summary: The clinical outcome of 153 Gravesdisease patients treated with a wide dose range of radioactive iodine-131 (RAI) was analyzed retrospectively. Six to nine months after the first dose of RAI 60 ...

7

Pediatric Graves’ disease: management in the post-propylthiouracil Era

Pediatric Graves’ disease: management in the post-propylthiouracil Era

... The most prevalent cause of thyrotoxicosis in children is Gravesdisease (GD), and remission occurs only in a modest proportion of patients. Thus most pediatric patients with GD will need treatment with ...

10

Association of TLR7 and TSHR copy number variation with Graves’ disease and Graves’ ophthalmopathy in Chinese population in Taiwan

Association of TLR7 and TSHR copy number variation with Graves’ disease and Graves’ ophthalmopathy in Chinese population in Taiwan

... 29. Ploski R, Brand OJ, Jurecka-Lubieniecka B, Franaszczyk M, Kula D, Krajewski P, Karamat MA, Simmonds MJ, Franklyn JA, Gough SC, et al: Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk ...

5

Neonatal Graves’ Disease and Cholestatic Jaundice: Case Series and Review of the Literature

Neonatal Graves’ Disease and Cholestatic Jaundice: Case Series and Review of the Literature

... with Gravesdisease 8 years previously and treated with radioactive iodine therapy resulting in hypothyroid- ...Grave’ disease was confirmed by presence of TSH receptor antibodies which were ...

6

An Adolescent With a Mediastinal Mass, Diagnosed With Graves Disease and Thymic Hyperplasia

An Adolescent With a Mediastinal Mass, Diagnosed With Graves Disease and Thymic Hyperplasia

... Graves disease is an autoimmune disorder characterized by thyroid enlargement and ...with Graves disease. We present here the case of a child with Graves disease and significant ...

7

Epidemiology, management and outcomes of Graves’ disease—real life data.

Epidemiology, management and outcomes of Graves’ disease—real life data.

... All data was recorded on an Excel spreadsheet. A number of key variables were validated by an independent second observer. Data analysis was primarily performed using the IBM SPSS statistics version 21 software package; ...

11

A Combined Case of Macroprolactinoma, Growth Hormone Excess and Graves’ Disease

A Combined Case of Macroprolactinoma, Growth Hormone Excess and Graves’ Disease

... A Combined Case of Macroprolactinoma, Growth Hormone Excess and Graves' Disease CASE REPORT A Combined Case of Macroprolactinoma, Growth Hormone Excess and Graves' Disease Z Hussein, MRCP*, B Tress**,[.] ...

5

Managing thymic enlargement in Graves’ disease

Managing thymic enlargement in Graves’ disease

... Thymic enlargement (TE) in Gravesdisease (GD) is often diagnosed incidentally when chest imaging is done for unrelated reasons. This is becoming more common as the frequency of chest imaging increases. ...

7

Change in BMI after radioactive iodine ablation for graves disease

Change in BMI after radioactive iodine ablation for graves disease

... Graves disease (GD), characterized by autoimmune over- stimulation of the thyroid gland, is the most common cause of hyperthyroidism in children and adolescents [1 – ...

5

Show all 10000 documents...

Related subjects